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Objective: Bipolar disorder (BPD) and normal aging are known to impact cognitive skills and health-related
quality of life (HRQOL). This study investigated how aging and disease interact in predicting cognitive and
psychosocial outcomes.
Methods: Eight cognitive and ten subjective HRQOL domain ratings were measured. Subjects included
80 young (18–29 years) and late middle-aged (50–65 years) BPD patients in the euthymic phase and 70
age-equivalent healthy comparison participants.
Results: An age X disease interaction was detected in three domains of cognitive functioning that reflect
emotion processing, processing speed, and executive functioning skills, with BPD patients in the older
group performing most poorly. There was a double burden of aging and disease on reported ability to
perform physical tasks. However, regardless of age, disease status was associated with lower ratings of
HRQOL in the psychosocial/affective sphere and the majority of cognitive domains. Post hoc analyses
revealed that number of years ill was positively associated with select HRQOL ratings in older, but
not younger BPD adults.
Conclusions: These findings may stimulate future longitudinal study of cognition and quality of life in
BPD patients across the life span, focusing on additive and interactive effects of aging and disease
burden, which could culminate in developing more effective treatment and rehabilitation strategies
for this traditionally challenging to treat population. Copyright # 2014 John Wiley & Sons, Ltd.
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Bipolar disorder, aging, and cognition
Deficits in psychomotor speed, attention, executive
functions, memory, and fine motor skills have been
widely reported in bipolar disorder (BPD), both
during active states of mania and depression and during
the euthymic state (van Gorp et al., 1998; Rubinsztein
et al., 2000; Zubieta et al., 2001; Altshuler et al., 2004;
Martinez-Aran et al., 2004; Burdick et al., 2006; Bora
et al., 2009; Langenecker et al., 2010). Normal aging is
also known to impact a number of cognitive skills
(Villardita et al., 1985), although how aging and disease
interact in the context of BPD is unclear. McKinney and
Sibille (2013) propose that age-related genetic func-
tional changes may promote vulnerability to develop
diseases, such as depression, through alterations in gene
expression for genes that are disease-promoting. A
similar model might be applied to the study of behavioral
consequences of early-onset mood disorders in the
context of aging. Specifically, age-related brain changes
may promote vulnerability to develop cognitive and
functional problems, which may be most evident in
domains for which decrement is associated with mood
disorder. Alternatively, or in addition to, change in
Copyright # 2014 John Wiley & Sons, Ltd. Int J Geriatr Psychiatry 2014; 29: 952–961
RESEARCH ARTICLE
domains that are impacted even early in the disease
process may demonstrate accelerated decline during
aging, as a result of increased vulnerability. To more
clearly explicate potential interactive and non-
interactive effects of age-disease effects in mood disor-
der, we propose a testable model that describes the
trajectory of cognition and function from young to
later life BPD (Figure 1).
There is a growing volume of literature concerning
cognition in middle aged and older adults with BPD.
Case-control studies of older euthymic BPD patients find
poorer performance in multiple cognitive domains, in-
cluding processing speed, language, visuomotor skills,
working memory, verbal fluency, episodic memory, ex-
ecutive functioning, and psychomotor speed (Delaloye
et al., 2009; Schouws et al., 2009; Gildengers et al.,
2012). Results from longitudinal studies of cognition in
middle-aged/older adults with BPD are variable,
depending upon the time frame studied. At two-year fol-
low-up, no differences in the trajectory of cognitive
changes were found, both relative to healthy, same-age
comparisons (Delaloye et al., 2011) nor when comparing
symptomatic to asymptomatic patients (Braw et al.,
2013). Another study conducted over 3 years, however,
found that BPD patients demonstrated more variability
in performance on a composite of global cognition,
relative to the healthy comparison group (Depp et al.,
2008). When the assessment period was lengthened to
9 years, young and middle-aged euthymic BPD patients
exhibited declined executive functioning, slight improve-
ment in attention, and no changes in verbal learning and
memory relative to healthy, age-matched comparison
groups (Torrent et al., 2012).
Although the aforementioned studies have elucidated
some of the cognitive problems that middle aged and
older patients with BPD experience, only two known
studies have included both younger and older samples
to assess the interaction of aging and disease. The first
study included both patients with BPD and unipolar
depression in the same group, and presumably, in both
active and euthymic/remitted states (though this is not
explicitly stated; Gualtieri and Johnson, 2008). Partic-
ipants were divided into five age groups from ages 18
to 86 years. Patients performed less well than same-
age comparison groups across all cognitive domains
assessed, and decline was shown to accelerate in
patients with mood disorders after the age of 65 years
in every domain except complex attention. In the
second study, 71 euthymic BPD patients and 82
healthy comparison participants, ranging in age from
18 to 70, underwent a short battery of cognitive tests.
When used as a covariate, age did not have any differ-
ential impact on performance for tests measuring
memory and executive functioning (Sarnicola et al.,
2009). These studies are limited, in that they either
included individuals in both the active and euthymic
states (in the case of the first study), or did not
study cognition comprehensively (in the case of the
second study).
Quality of life in bipolar disorder
While there has been a great deal of attention paid to
cognition in the context of aging and disease, less
emphasis has been placed on subjective quality of life,
which, although related to cognitive skills, should be
considered separately for the purpose of treatment
outcomes. It is well documented that individuals with
BPD report a lower quality of life than their healthy
counterparts, both in the realms of physical and men-
tal health (Michalak et al., 2005; Bonnin et al., 2012).
Further, with normal aging comes greater variability
in quality of life, given higher rates of physical disease
burden and disability than during younger ages. It is
not clear, however, how aging and disease interact with
subjective health-related quality of life (HRQOL),
which is highly relevant to treatment providers caring
for older adults with BPD.
Aims of the current study
This study was implemented to address methodologi-
cal and power weaknesses in the literature that have
precluded the field from understanding critical disease
and age-related issues and interactions. It sought to
explicate how aging and disease interact in impacting
cognitive function and HRQOL ratings among
Figure 1 Potential interactive and non-interactive effects of age and
bipolar disease.
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younger and older middle-aged BPD patients in the
euthymic phase of illness relative to age-equivalent
non-BPD peers. Consistent with previous literature
on cognitive functioning in normal aging and in
BPD, we expected age and BPD to interact, such that
older middle-aged adults with BPD would perform
most poorly on measures of cognitive functioning
that are particularly sensitive to the effects of disease
and aging, including executive functioning, memory,
and processing speed. In the model proposed, this
would be observed as an accelerated or compounded
effect of disease with aging. We predicted an interac-
tion of age and disease on HQROL ratings, such that
the older group with BPD would be especially prone
to report lower quality of life ratings, both in physical
and emotional domains, such that a compounded ef-
fect of disease with aging is observed.
Methods
Participants
Study participants were recruited for the Heinz C.
Prechter Longitudinal Bipolar Study, a study of
phenotypic and biological outcomes of BPD at the
University of Michigan from October 2005 to
December 2010 (Langenecker et al., 2010). Recruit-
ment methods and inclusion/exclusion criteria have
been reported previously (Langenecker et al., 2010)
and are included in supplemental material. Of the
586 participants recruited for the longitudinal cohort,
80 individuals with confirmed BPD I (n= 70) or BPD
II (n= 10) in the euthymic state and 78 healthy
comparison (HC) subjects were included in the pres-
ent study. We specifically selected individuals younger
than 30 years and ages 50 to 65 years for inclusion in
the current comparison study, although the larger lon-
gitudinal cohort includes individuals aged 18 to
65 years, as well as patients with active state BPD.
The BPD and HC groups extracted from the larger
data set were matched for age, then education, then
sex, resulting in the exclusion of nine BPD patients
and 33 HC. More specifically, matches for BPD
patients were derived from the HC group for age
within 2 years, then education within 2 years, and
finally sex. Of note, there are three more males in
the HC group than the BPD group and five more
females in the BPD group relative to the HC group.
This study was approved by the Institutional
Review Board at the University of Michigan, and all
participants gave informed consent prior to participa-
tion. The sample was divided into two age groups:
those between the ages of 18 and 29 years (n= 95)
and those aged 50 to 65 years (n= 63). Within each
of the younger and older groups, there were no signif-
icant differences between the BPD and HC groups on
age, education, or sex (Table 1).
Clinical variables
Clinical variables were extracted from the baseline
Diagnostic Interview for Genetic Studies (Nurnberger
et al., 1994), including medication loading (Hassel
et al., 2008) and years of illness. Table 1 characterizes
the young and older BPD groups on all clinical variables.
Measures
All participants received a research-defined compre-
hensive neuropsychological evaluation that focused
on areas known to be adversely impacted in
BPD, including memory, attention and executive
functioning, psychomotor speed, and emotion pro-
cessing (Langenecker et al., 2010) and completed a
self-report measure of HRQOL, the Short Form 36
Health Survey (SF-36; McHorney et al., 1993,
Table 1 Sample demographic and clinical characteristics*
Sex Age Educ. HAM-D YMRS Years Ill• MedBur
Young HC 20 M 28 F 24.3±3.2 15.8±1.9 1.2±1.6 0.2±0.5 — —
Young BPD 20 M 27 F 24.1±3.1 15.1±1.8 3.2±3.1 1.0±1.7 7.8±4.7 1.3±1.9
Older HC 17 M 13 F 56.9±4.0 15.6±2.3 0.2±0.3 0.3±0.6 — —
Older BPD 14 M 19 F 56.4±4.7 16.5±2.1 2.8±2.6 0.8±1.3 35.8±7.8 1.4±1.7
HC, healthy control; BPD, bipolar disorder; M, male; F, female; Educ., education; HAM-D, Hamilton Depression Rating Scale (Hamilton, 1967);
YMRS, Young Mania Rating Scale (Young et al., 1978); MedBur, medication burden.
The majority of participants classified themselves as Caucasian (64 BPD, 58 HC). The sample also consisted of individuals classifying themselves as
Black or African American (5 BPD, 8 HC), Asian (4 BPD, 7 HC), American Indian/Alaskan Native (1 HC), and More Than One Race (4 BPD, 4
HC). Race was not reported for two BPD participants. Refer to Table 1 for a complete characterization of sample demographics.
•Older individuals with BPD reported greater years of illness relative to younger individuals with BPD, t(77) =18.40, p< 0.001.
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1994; Ware and Sherbourne, 1993). Standard data
reduction techniques were utilized using conceptu-
ally and theoretically categorized variables (see
Langenecker et al., 2010 for a full description).
Truncation was carried out separately for BPD and
HC to avoid biases of misapplication from one
group to another. Supplemental Table 1 lists the
measures included in each cognitive domain and
the internal consistency value for this particular
sample for factors with three or more variables.
Statistical analyses
The alpha level was set at p< 0.05 for all analyses
using SPSS 19.0. Independent t-tests and chi-square
analyses were performed to test between-group
differences in demographic variables. Multivariate
analyses (MANOVA) were completed to examine the
effects of age (young versus middle aged) and diagno-
sis (BPD versus comparison), and the interaction of
age and diagnosis on the eight cognitive factor scores
and subscales of the SF-36, respectively. Education
was entered as a covariate for the MANOVA for
cognitive factors, as education is associated with
cognitive reserve (Liu et al., 2013) and may obscure
age by disease interactions. A series of post hoc explor-
atory multiple regression analyses were computed to
investigate the impact of clinical variables on cognitive
performance and HRQOL ratings in the BPD group.
We were interested in evaluating independent contri-
butions of age and duration of illness; however,
because they were so highly correlated (r= 0.93), this
disallowed for independent evaluations. As a result,
we elected to perform regression analyses separately
for the younger and middle-aged groups. To further
prevent against confounding years of illness with age,
the years of illness variable was normalized to a z distri-
bution within each age group. In the first step of each
regression, education (for cognitive variables only)
and symptom severity ratings (Hamilton Depression
Rating Scale and Young Mania Rating Scale scores)
were entered, and in the second step, medication load
and normalized years of illness were entered. Data for
years of illness was missing for one subject. Because
participants in the BPD group were taking a number
of medications that varied in class and dose that could
impact cognitive functioning, we quantified medication
load by using criteria based on prior literature (Hassel
et al., 2008; Almeida et al., 2009; see supplemental ma-
terial for complete description). Medication load was
missing for five participants.
Results
Group comparisons for cognitive performance
The main effects of age group, F(8, 124) = 12.57,
p< 0.001, and diagnosis, F(8, 124) = 4.59, p< 0.001
were significant in the omnibus MANCOVA analysis.
The interaction of age group by diagnosis was not
significant, F(8, 124) = 1.07, p= 0.39. Education was
a significant covariate, F(8, 124) = 2.95, p< 0.01. Post
hoc analysis of covariances revealed main effects of
age group for all eight cognitive factors. Main effects
of diagnosis were detected for fine motor, visual mem-
ory, emotion processing, verbal fluency and process-
ing speed (VFPS), and processing speed with
interference resolution (PSIR). A significant interac-
tion of age group by diagnosis was found for emotion
processing, VFPS, and PSIR, (Table 2 and Figure 2).
Follow-up analysis of covariances were conducted for
these three factors to determine the specific nature of
the interaction (Table 3). In the younger group,
individuals with BPD performed more poorly than
comparisons only in the domain of PSIR. Younger
groups were equivalent for emotion processing and
VFPS. In contrast, in the middle-aged group, BPD
patients performed significantly more poorly than
comparisons in PSIR and VFPS, with marginally
significant differences detected for emotion process-
ing. Thus, in the proposed model, PSIR represents a
compounded effect of disease in the context of aging,
whereas VFPS and emotion processing represent an
accelerated effect of disease in the context of aging.
Group comparisons for quality of life
The main effects of age group, F(8, 119) = 5.65,
p< 0.001, and diagnosis, F(8, 119) = 8.89, p< 0.001,
and the interaction of age group X diagnosis, F(8,
119) = 2.24, p< 0.05, were significant in the omnibus
MANOVA analysis. Post hoc analysis of variances
revealed main effects of age for physical functioning,
role-physical, bodily pain, and the physical health
component score. The main effect of diagnosis was
present for all eight domains of functioning and the
physical health and mental health component scores.
A significant interaction of age group X diagnosis
was detected for role-physical (Table 4, Figure 3).
Follow-up t-tests were conducted for this factor to
determine the specific nature of the interaction
(Table 3). Although both younger and middle-aged
BPD participants rated themselves as having lower
quality of life than their comparison peers, the
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difference was larger in the older group. Thus, in the
proposed model, functioning with regard to physical
role would represent a compounded effect of disease
in the context of aging.
Relationships of cognitive performance to clinical variables
in BPD patients
After accounting for the impact of education
(cognitive outcomes only) and symptom severity,
years of illness positively predicted Role-Emotional
(t= 2.48, p= 0.02) and the Mental Component Scale
(t= 2.32, p= 0.03) on the SF-36 in the older group
only. Years of illness predicted none of the HRQOL
ratings in the younger group and did not predict
cognitive performance in either group. Medication
burden predicted social function (t= -2.15, p=0.04)
in the younger group.
Table 2 Cognitive functioning across eight domains by age and disease status, covarying for education
Cognitive measure Source F p
Fine motor dexterity Education 2.63 0.107
Age group 41.19 <0.001
BPD status 15.36 <0.001
Age group X BPD status 1.73 0.190
Auditory memory Education 9.13 0.003
Age group 6.04 0.015
BPD status 0.00 0.984
Age group X BPD status 0.03 0.863
Visual memory Education 0.03 0.858
Age group 20.76 <0.001
BPD status 6.56 0.012
Age group X BPD status 1.28 0.260
Emotion processing Education 5.23 0.024
Age group 75.56 <0.001
BPD status 5.11 0.025
Age group X BPD status 5.18 0.024
Verbal fluency and Education 11.81 0.001
processing speed Age group 16.97 <0.001
BPD status 10.23 0.002
Age group X BPD status 3.97 0.048
Conceptual reasoning Education 11.21 0.001
Cognitive measure Source F p
and set shifting Age group 12.32 0.001
BPD status 1.02 0.315
Age group X BPD status 1.39 0.240
Processing speed with Education 5.76 0.018
interference resolution Age group 46.13 <0.001
BPD status 28.20 <0.001
Age group X BPD status 4.94 0.028
Inhibitory control Education 1.49 0.224
Age group 5.65 0.019
BPD status 3.39 0.068
Age group X BPD status 0.06 0.804
BPD, bipolar disorder.
df = (1131) for all variables.
Figure 2 Disease by age on cognitive functioning. The main effect of
age is significant for all eight cognitive factors. The main effect of diag-
nosis is significant for fine motor dexterity, visual memory, emotion
processing, verbal fluency and processing speed, and processing speed
with interference resolution. A significant interaction of age by diagno-
sis is present for emotion processing, verbal fluency and processing
speed, and processing speed with interference resolution (all ps< 0.05).
Performance values are in z scores, which have a mean of 0 and SD of 1.
Note: HC, healthy control; BPD, bipolar disorder; FineMot, fine motor
dexterity; AudMem, auditory memory; VisMem, visual memory;
EmPrc, emotion processing; VFPS, verbal fluency and processing
speed; CRSS, conceptual reasoning and set shifting; PSIR, processing
speed with interference resolution; IC, inhibitory control.
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Discussion
This study considers the double burden of aging and
disease status on cognition and HRQOL in the context
of BPD. Late middle-aged euthymic adults with BPD
demonstrate particularly poorer performance in the
domains of emotion processing, processing speed,
and aspects of executive functioning (i.e., verbal flu-
ency, attentional shifting, and interference resolution).
PSIR demonstrated a compounded effect with aging in
the context of BPD, while VFPS and emotion process-
ing characterized an accelerated effect of aging in BPD.
At the same time, verbal memory and other aspects of
executive functioning, such as inhibitory control,
conceptual reasoning, and set shifting were impacted
only by age, regardless of disease status. Both aging
and disease impacted fine motor skills and visual
memory skills, albeit independently. Results are con-
sistent with past work identifying worsened executive
functioning skills and slower processing speed in mid-
dle aged and older adults with BPD relative to their
non-BPD peers (Delaloye et al., 2009, 2011; Schouws
et al., 2009; Gildengers et al., 2012; Braw et al.,
2013). A meta-analysis of cognitive dysfunction in
euthymic BPD identified moderate to large effect sizes
for executive functioning, processing speed, in addition
to memory in euthymic BPD (Torres et al., 2007).
Thus, when the effects of aging are compounded with
potentially long standing pathophysiology in areas of
the brain underlying these skills, it is not surprising to
find especially poor performance in these domains
among older people with BPD.
Findings are in contrast to previous work finding
verbal memory deficits in aging BPD patients relative
to same-age healthy comparisons (Delaloye et al.,
2009; Schouws et al., 2009; Gildengers et al., 2012).
It is likely that the age of our older sample
(50–65 years) explains the discrepancy in findings, as
the aforementioned studies included older partici-
pants than the current sample. Participants in our
sample were also highly educated, and thus likely
presented with more cognitive reserve than partici-
pants in the majority of studies. Further, Schouws
and colleagues (2009) also included patients with
late onset BPD, whereas we limited our sample to
those with early-onset BPD. It is possible that pro-
cessing speed and executive functioning decline at
an earlier age than do memory skills in middle aged
and older adults with BPD, though this conjecture
would need to be confirmed with a longitudinal
study. Certainly, findings of declined executive
functioning, but not memory, among BPD patients
over 9 years (Torrent et al., 2012) would lend partial
support to this possibility.
Affective processing deficits have been studied less
often, relative to other cognitive skills, in middle-aged
and older patients with BPD, though our cross-sectional
results suggest that they may decline at an accelerated
Table 3 Post hoc tests for significant age by disease interactions
Age group Cognitive domain Source df F/t p
Young
Emotion processing Education 1 7.74 0.007
BPD status 1 0.16 0.694
Error 85
Verbal fluency with proc speed Education 1 3.58 0.062
BPD status 1 1.66 0.201
Error 88
Proc speed with interference resolution Education 1 1.71 0.195
BPD status 1 8.7 0.004
Error 85
Role-physical BPD status 1 0.038
Error 76 5.71 <0.001
Middle-aged Emotion processing Education 1 2.41 0.126
BPD status 1 3.35 0.072
Error 56
Verbal fluency with proc speed Education 1 8.51 0.005
BPD status 1 11.7 0.001
Error 58
Proc speed with interference resolution Education 1 3.85 0.055
BPD status 1 20.67 <0.001
Error 55
Role-physical BPD status 1 3.01 0.004
Error 52
BPD, bipolar disorder.
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pace with age. Interestingly, a longitudinal structural
imaging study of 20 adults with BPD demonstrated
larger declines in hippocampus and fusiform gyrus over
4 years as compared with same-age comparisons
(Moorhead et al., 2007). These regions are important
to emotion processing, and such neurodegenerative
changes may help explain why the older patients with
BPD performed particularly poorly on measures of
emotion processing.
Our results also suggest that there is a compounded
effect of aging and disease in the reported ability of a
person to perform physical tasks, and aging negatively
contributes to nearly all aspects of physical health,
though it is a disease status, regardless of age group,
that adversely impacts emotional health characteris-
tics, such as having a sense of vitality and the ability
to engage in social interactions. Thus, while select
cognitive skills and engagement in physical activities
may demonstrate accelerated changes with aging in
the context of BPD, emotional health ratings are not
augmented with aging in BPD. Rather, emotional
health is uniformly lower in both younger and older
Table 4 Health-related quality of life ratings by age and disease status
HRQOL subscale Source F p
Physical functioning Age group 16.53 <0.0001
BPD status 24.40 <0.0001
Age group X BPD status 1.83 0.178
Role-physical Age group 5.35 0.022
BPD status 25.23 <0.0001
Age group X BPD status 6.30 0.013
Bodily pain Age group 4.53 0.035
BPD status 11.37 0.001
Age group X BPD status 0.21 0.647
General health Age group 0.46 0.501
BPD status 26.76 <0.0001
Age group X BPD status 0.75 0.387
Physical health component Age group 12.87 <0.0001
BPD status 10.49 0.002
Age group X BPD status 3.02 0.085
Vitality Age group 3.39 0.068
BPD status 51.66 <0.0001
Age group X BPD status 1.76 0.187
Social functioning Age group 0.04 0.849
BPD status 51.79 <0.0001
Age group X BPD status 0.02 0.895
HRQOL subscale Source F p
Role-emotional Age group 0.98 0.324
BPD status 36.92 <0.0001
Age group X BPD status 1.30 0.256
Mental health Age group 0.14 0.708
BPD status 51.84 <0.0001
Age group X BPD status 0.16 0.693
Mental health component Age group 3.89 0.051
BPD status 54.73 <0.0001
Age Group X BPD status 1.83 0.179
BPD, bipolar disorder; HRQOL, health-related quality of life.
df = (1126) for all variables.
Figure 3 Disease by age on self-reported physical and emotional function-
ing. Significant effects of age are present for physical functioning, role-phys-
ical, bodily pain, and the physical health component score (not depicted).
The main effect of diagnosis is found for all eight domains of functioning
and the Physical andMental Health component scores (not depicted). A sig-
nificant interaction of age X diagnosis is detected for role-physical (all ps
0.05). Performance values are in z scores, which have a mean of 0 and SD
of 1. Note: HC, healthy control; BPD, bipolar disorder; Phys Func, physical
functioning; Role Phys, role-physical; Gen Health, general health; Social
Func, social functioning; Role Emot, role-emotional.
958 S. L. Weisenbach et al.
Copyright # 2014 John Wiley & Sons, Ltd. Int J Geriatr Psychiatry 2014; 29: 952–961
patient groups, relative to the comparison group. In
the younger BPD group only, medication burden was
related to poorer ratings in the domain of Social
Function, perhaps suggesting that disease burden
and/or medication side effects impact a person’s abil-
ity to engage in social relationships to a degree that is
satisfying. It is important for caregivers working with
aging BPD patients to identify physical limitations
and work toward assisting patients in identifying solu-
tions, particularly given the difficulties that some of
these patients have with executive functioning that
can impair planning and problem-solving. Clinicians
working with BPD patients of all ages would be
advised to not only treat symptoms of the illness, but
also to attend to perceptions of quality of life in the
emotional domain. The difficulties that we observe
here may underestimate limitations observed in actual
clinical practice where individuals are more likely to
have active disease state.
In an effort to understand why age and disease
status exert an interactive effect on aspects of cognitive
skills and HRQOL, we investigated two clinical vari-
ables in post hoc fashion that might serve as proxies
for age by disease interactions, including medication
burden and years of illness in predicting performance
across cognitive domains, after considering the impact
of education (for cognitive variables only) and symp-
tom severity. Surprisingly, only years of illness were
positively associated with HRQOL for physical role
and overall mental health functioning, and only in
the older group. This finding might suggest that indi-
viduals who have lived with BPD for the longest time
have the best quality of life ratings, suggesting that ex-
perience with the illness over time may increase resil-
ience. None of the clinical variables measured
significantly predicted cognitive performance for any
of the cognitive variables. It is notable that there is
likely a complex relationship between medication use
and cognitive functioning. For example, Lithium can
confer neuroprotective effects, but also has anticholin-
ergic properties that can alter cognitive functioning
(Gray and McEwen, 2013). The proxy variables that
we used for quantifying the interactive effects of age
and disease were largely not successful in predicting
variation in cognitive performance and HRQOL
ratings in either younger or older adults. Other
variables, such as number of hospitalizations, num-
ber of psychotic episodes, and/or neurobiological
measures, such as cortisol may be better proxy vari-
ables to use in future study of mechanisms of age
by disease interactions.
This study has a few limitations that should be
considered in the interpretation of its results. First,
this is a cross-sectional study, and although we can
make inferences about how cognitive skills change
over time among adults with BPD, only longitudinal
studies can answer this question definitively. Other
sources of cognitive differences between younger and
older groups might relate to cohort differences,
changes in treatment approaches throughout the
years, and so on. Second, we chose to examine two
distinct age groups, 18–29 years and 50–65 years, in
order to include adults at either end of the younger
and middle-age groups, and also not to confound
results with potential hormonal variations that can
occur during peri-menopause in women. However,
this approach did not allow us to make inferences
about cognitive changes that might occur during early
middle age, which might also be relevant, or their
longitudinal course. Third, most of the patients were
medicated, and although we attempted to investigate
the impact of medication burden on outcome
variables, we were underpowered to more explicitly
investigate specific medication effects. Fourth, it is
possible that older patients with BPD experience a
greater number of medical comorbidities than do
other groups (Lala and Sajatovic, 2012), although this
was not specifically assessed. Fifth, in exploratory
regression analyses, we had to approach the impact
of duration of illness on cognition and health-related
quality of life ratings in a non-ideal manner because
of the high correlation between age and duration of
illness, disallowing for adequate disassociation of
age-driven versus illness-loading effects. This would
require a prospective longitudinal approach to ad-
dress this question with any certainty. Finally, the
sample was well educated. Given that education has
been related to cognitive reserve (Liu et al., 2013),
even greater differences in cognition among aging
BPD patients may be detected in studies with less
educated participants.
Conclusion
Aging in the context of BPD impacts specific cognitive
skills, including aspects of executive functioning,
processing speed, and emotion processing, as well as
HRQOL in the physical role domain. Clinical variables
that might help us to understand age by disease
interactions in BPD were, by and large, not successful
in predicting cognitive performance or HRQOL
ratings. Future work might include the longitudinal
assessment of euthymic BPD patients across the age
spectrum with comprehensive neuropsychological
evaluation and quality of life measurement, all of which
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are relevant to clinicians working with BPD patients.
Knowing the progression of cognitive difficulties in
aging BPD patients is likely to stimulate more
specific cognitive rehabilitation trials that could func-
tion to help older BPD patients compensate for cogni-
tive loss.
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Key Points
• Late middle-aged euthymic adults with Bipolar
Disorder (BPD) demonstrate particularly poor
performance in the domains of emotion pro-
cessing, processing speed, and aspects of executive
functioning, relative to younger patients with
BPD and same-age healthy peers.
• Verbal memory and other aspects of executive
functioning, such as inhibitory control, conceptual
reasoning, and set shifting are impacted only by
age, regardless of disease status, while both aging
and disease impact fine motor and visual memory
skills, albeit independently.
• There is a double burden of aging and disease in
BPD that impacts the reported ability of a person
to perform daily physical tasks.
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